Added to YB: 2019-10-23
Pitch date: 2019-10-23
MLNT [bearish]
Melinta Therapeutics, LLC
+97.68%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Melinta Therapeutics, LLC, a commercial-stage pharmaceutical company, discovers, develops, and commercializes various anti-infectives for the treatment of bacterial infectious diseases in North America.
Market Cap
$1.5M
Pitch Price
$4.75
Price Target
N/A
Dividend
N/A
EV/EBITDA
N/A
P/E
-0.00
EV/Sales
N/A
Sector
Pharmaceuticals
Category
N/A
Show full summary:
MELINTA THERAPEUTICS INC MLNT
A summary for this pitch has not been created yet.
Read full article (0 min)